BioSpace News Archive

Radionetics Oncology announced the appointment of Umesh Gangadharmath, Ph.D. as Senior Vice President, Technical Operations.

Foresight Diagnostics, Inc, a leader in cancer diagnostics and cancer relapse testing, announced today that the U.S. Patent and Trademark Office (USPTO) has granted the company patent No.11,447,833 for the detection of minimal residual disease (MRD) using its personalized phased variant detection platform.

The global neuroscience market was reached at US$ 28.3 billion in 2020 and predicted to surpass around US$ 41.4 billion by 2030, expanding at a noteworthy CAGR of 4.1% from 2021 to 2030.

The global latent tuberculosis infection detection market was surpassed at USD 1,251.62 million in 2021 and is expected to hit around USD 1,954.36 million by 2030, growing at a CAGR of 5.64% from 2022 to 2030.

Tarsus Pharmaceuticals, Inc. today announced that the results from the Saturn-2 pivotal Phase 3 trial of TP-03 (lotilaner ophthalmic solution, 0.25%) in Demodex blepharitis patients will be presented at the upcoming World Cornea Congress (WCC) VIII and the American Academy of Ophthalmology (AAO) 2022 Annual Meetings in Chicago, Illinois.

AustinPx, Pharmaceutics and Manufacturing, a contract development and manufacturing organization, announced the appointment of Elizabeth Hickman as Chief Business Officer.

The global PEGylated proteins market was surpassed at USD 12,786 million in 2021 and is expected to hit around USD 22,967 million by 2030, growing at a CAGR of 7.2% from 2022 to 2030.

The latest market analysis report published by Reports and Data, titled ‘Global Alagille Syndrome Market – Forecast to 2030,’ thoroughly examines the Alagille Syndrome industry to provide essential data & information for the targeted readers.

Arsenal Biosciences, Inc. today announced a multi-year collaboration with Genentech, a member of the Roche Group.

Kintara Therapeutics, Inc. today announced financial results for its fiscal year ended June 30, 2022 and provided a corporate update.